Kintara Therapeutics has started a clinical trial to study REM-001, targeting patients with cutaneous metastatic breast cancer (CMBC).
This trial, which is open to...
A new multi-institutional study, led by a team of researchers including Prof Carlo Palmieri, Prof Hannah Linden, and others, investigated the effectiveness and safety...
Patients with a type of breast cancer that grows in response to estrogen (ER-positive) but does not have the HER2 protein (HER2-negative) often start...
Atossa Therapeutics Inc has recently made an announcement about progress in one of its breast cancer studies.
They've completed enrolling participants for a specific...